cantex.comHealthcareFounded: 2002Funding to Date: $67.87MM
Cantex Pharmaceuticals develops novel treatments for inflammatory lung diseases and cancer.
For more details on financing and valuation for Cantex Pharmaceuticals, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Cantex Pharmaceuticals.
To read this article and more news on Cantex Pharmaceuticals, register or login.
